Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the pulmonology devices market grown in recent years?
There has been a swift expansion in the market size of pulmonology devices in the past few years. The market is predicted to escalate from $1.36 billion in 2024 to $1.51 billion in 2025, registering a compound annual growth rate (CAGR) of 11.0%. The unprecedented growth during the historic period is credited to the increase in chronic respiratory diseases, the growing preference for preventive healthcare, higher adoption of pulmonology devices, a rise in the number of cases needing endoscopic ultrasound operations, and an increasing older population.
How is the pulmonology devices market size expected to evolve during the forecast period?
The pulmonology devices market size is expected to see rapid growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rise in prevalence of respiratory diseases, rising air pollution levels, growth in home healthcare, growing awareness and early diagnosis, expansion of healthcare infrastructure. Major trends in the forecast period include integration of artificial intelligence, growth of telemedicine and remote monitoring, advancements in portable and wearable devices, use of robotic technology in less-invasive diagnostic procedures, increase in home care services.
Get your pulmonology devices market report here!
https://www.thebusinessresearchcompany.com/report/pulmonology-devices-global-market-report
Which key drivers are propelling the pulmonology devices market’s growth?
The escalating incidence of respiratory disorders is anticipated to drive the expansion of the pulmonology devices market in the future. Respiratory illnesses comprise various medical conditions impacting the organs and tissues that facilitate breathing, such as the airways, lungs, and respiratory muscles. The increasing cases of these diseases can be attributed to growing air pollution, smoking habits, and occupational risks. Devices for pulmonology aid in the handling of respiratory diseases by facilitating accurate identification, continuous observation, and effective treatment using tools such as spirometers, inhalers, pulse oximeters, and ventilators, consequently enhancing patient results and lifestyle quality. For example, the Australian Institute of Health and Welfare, a health and welfare organization based in Australia, reported in June 2024 that roughly 8.5 million individuals or 34% of the population in Australia were believed to have chronic respiratory conditions. This includes an estimated 2.8 million individuals or 11% of the population who live with asthma, and approximately 638,000 individuals or 2.5% of the population with chronic obstructive pulmonary disease (COPD). Hence, the escalating incidence of respiratory disorders is propelling the expansion of the pulmonology devices market.
What are the market segments in the pulmonology devices industry?
The pulmonology devices market covered in this report is segmented –
1) By Product Type: Endobronchial Ultrasound (EBUS) Needles, Pulmonary Biopsy Devices, Airway Stents, Single-Use Bronchoscopes, Other Product Types
2) By Indication: Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Tracheal And Bronchial Stenosis, Foreign Body Extraction, Other Indications
3) By End-User: Pulmonology Clinics, Hospitals, Ambulatory Surgical Centers
Subsegments:
1) By Endobronchial Ultrasound (EBUS) Needles: Radial EBUS Needles, Linear EBUS Needles, Biopsy EBUS Needles, EBUS Needles With Safety Features, EBUS Needles For Peripheral Lung Lesions
2) By Pulmonary Biopsy Devices: Core Biopsy Needles, Fine Needle Aspiration (FNA) Biopsy Devices, Vacuum-Assisted Biopsy Devices, Transthoracic Biopsy Devices, Endoscopic Pulmonary Biopsy Devices
3) By Airway Stents: Self-Expanding Airway Stents, Balloon-Expandable Airway Stents, Silicone Airway Stents, Metal Airway Stents, Hybrid Airway Stents (Silicone + Metal)
4) By Single-Use Bronchoscopes: Single-Use Flexible Bronchoscopes, Single-Use Rigid Bronchoscopes, Single-Use Pediatric Bronchoscopes, Single-Use Disposable Video Bronchoscopes, Single-Use Bronchoscopes With Integrated Suction
5) By Other Product Types: Pulmonary Function Testing Devices, Nebulizers For Pulmonary Disease Treatment, Spirometers, Pulmonary Inhalation Devices, Non-Invasive Ventilation (NIV) Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16772&type=smp
Who are the dominant players expanding their reach in the pulmonology devices market?
Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Baxter, Boston Scientific Corporation, Medline Industries LP., Olympus Corporation, Omron Healthcare, ResMed, Getinge, ICU Medical Inc., Fisher & Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG & Co. KGaA, NIOX
What are the key trends shaping the future of the pulmonology devices market?
Leading corporations in the pulmonology devices industry are pioneering novel products equipped with cutting-edge technologies, including bilevel positive airway pressure (BiPAP) tech, to optimize patient comfort, amplify efficacy of treatments and cater to a variety of respiratory conditions. BiPAP technology incorporates dual pressure settings, an inhalation (IPAP) and an exhalation (EPAP) setting, resulting in consistent comfort for the users. To exemplify, in February 2024, ResMed—a US-based firm offering cloud-connected apparatus—unveiled AirCurve 11, a series of advanced BiPAP machinery constructed to enhance convenience and compliance for sleep apnea patients and others with respiratory complications. The AirCurve 11 VAuto unit delivers higher and lower pressure during exhalation, tailored to sync with the patient’s inherent breathing rhythm. The AirCurve 11 ASV is an adaptive servo-ventilation (ASV) tool that measures 13 breathing points 50 times every second in order to regulate the patient’s ventilation.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16772
Which geographic areas are influencing the growth of the pulmonology devices market?
North America was the largest region in the pulmonology devices market in 2024. The regions covered in the pulmonology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024
Cardiovascular Surgery Devices And Equipment Global Market Report 2024
Portable X-Ray Devices Global Market Opportunities And Strategies To 2022
https://www.thebusinessresearchcompany.com/report/portable-x-ray-devices-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
